An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans
Cannabis is the most commonly used illicit substance worldwide. Recent years have seen an increase in cannabis consumption, and with new approvals and therapeutic indications, there are challenges in minimizing the risks and interactions between cannabis-based products, cannabis prescription drugs,...
Saved in:
| Main Authors: | Dolly Andrea Caicedo, Clara Pérez-Mañá, Magí Farré, Esther Papaseit |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/3/319 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of cannabis use on ageing and longevity: a systematic review of research insights
by: Sonam Nain, et al.
Published: (2025-07-01) -
19 patients report seizure freedom with medical cannabis oil treatment for drug-resistant epilepsy: a case series
by: Frank Yizhao Chen, et al.
Published: (2025-05-01) -
The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review
by: Nadia A. Leen, et al.
Published: (2024-10-01) -
The roles of cannabis potency and gender in cannabis dependence and anxiety in recent cannabis users with trauma exposure histories
by: T. Snooks, et al.
Published: (2025-02-01) -
<i>Cannabis sativa</i> L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat
by: Joanna Bartkowiak-Wieczorek, et al.
Published: (2024-08-01)